Phenoperidine

Phenoperidine

SCHEMBL28832646

CCOC(=O)C1(c2ccccc2)CCN(CCC(O)c2ccccc2)CC1.CCOC(=O)C1(c2ccccc2)CCN(CCc2ccc(N)cc2)CC1

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRK1OPRM1

The experimentally established mechanism targets of Phenoperidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
OPRM1 known ✓ P35372 9/20 0.56
OPRK1 known ✓ P41145 6/20 0.56
KCNA3 P22001 3/20 0.67
OPRD1 P41143 7/20 0.56
SLC22A1 O15245 1/20 0.53
SLC6A4 P31645 1/20 0.53
ADRA1A P35348 1/20 0.53
KCNH2 Q12809 1/20 0.53
KDM4E B2RXH2 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Anileridine SCHEMBL26333 0.91 KCNA3 (0.74) KCNA3OPRM1OPRD1OPRK1SLC22A1
Anileridine SCHEMBL27722317 0.91 KCNA3 (0.74) KCNA3OPRM1OPRD1OPRK1SLC22A1
Anileridine SCHEMBL119086 0.90 KCNA3 (0.72) KCNA3OPRM1OPRD1OPRK1SLC22A1
Anileridine SCHEMBL7119028 0.90 KCNA3 (0.72) KCNA3OPRM1OPRD1OPRK1SLC22A1
Phenoperidine SCHEMBL80415 0.89 KCNA3 (0.83) KCNA3OPRM1OPRD1OPRK1SLC22A1
Phenoperidine SCHEMBL394330 0.88 KCNA3 (0.81) KCNA3OPRM1OPRD1OPRK1SLC22A1
Phenoperidine SCHEMBL1652634 0.88 KCNA3 (0.80) KCNA3OPRM1OPRD1OPRK1SLC22A1
Anileridine SCHEMBL1237724 0.87 KCNA3 (0.69) KCNA3OPRM1OPRD1OPRK1SLC22A1
Anileridine SCHEMBL8741179 0.84 KCNA3 (0.66) KCNA3OPRM1OPRD1OPRK1SLC22A1
Pheneridine SCHEMBL1922392 0.83 KCNA3 (0.86) KCNA3OPRM1OPRD1OPRK1SLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103717597-B Heterocyclic compounds as kinase inhibitors 原真股份有限公司 2017-07-04 CN disclosed
CN-103492389-B Pyrazolo [4,3-d] pyrimidine as inhibitors of kinases 原真股份有限公司 2016-09-14 CN disclosed